Parenteral Drugs (India) Ltd.

Parenteral Drugs (India) Ltd.verified

PDPL.NS

Price:

$2.9

Market Cap:

$101.08M

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-08-19

Stock Exchange

NSE

Ticker

PDPL.NS

The Enterprise Value as of November 2025 (TTM) for Parenteral Drugs (India) Ltd. (PDPL.NS) is 1.17B

According to Parenteral Drugs (India) Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.17B. This represents a change of 100.80% compared to the average of 584.20M of the last 4 quarters.

Parenteral Drugs (India) Ltd. (PDPL.NS) Historical Enterprise Value (quarterly & annually)

How has PDPL.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Parenteral Drugs (India) Ltd. over the last ten years is 7.25B. The current 1.17B Enterprise Value has changed 1.52% with respect to the historical average. Over the past ten years (40 quarters), PDPL.NS's Enterprise Value was at its highest in in the March 2021 quarter at 10.81B. The Enterprise Value was at its lowest in in the June 2012 quarter at 0.

Quarterly (TTM)
Annual

Average

7.25B

Median

7.50B

Minimum

1.18B

Maximum

10.81B

Parenteral Drugs (India) Ltd. (PDPL.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Parenteral Drugs (India) Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 34.26%

Maximum Annual Enterprise Value = 10.81B

Minimum Annual Increase = -89.09%

Minimum Annual Enterprise Value = 1.18B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20221.18B-89.09%
202110.81B13.33%
20209.54B10.42%
20198.64B-0.99%
20188.72B19.58%
20177.30B-5.23%
20167.70B34.26%
20155.73B-2.01%
20145.85B-16.93%
20137.04B11.01%

Parenteral Drugs (India) Ltd. (PDPL.NS) Average Enterprise Value

How has PDPL.NS Enterprise Value performed in the past?

The current Enterprise Value of Parenteral Drugs (India) Ltd. (PDPL.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.18B

5-year avg

7.78B

10-year avg

7.25B

Parenteral Drugs (India) Ltd. (PDPL.NS) Enterprise Value vs. Peers

How is PDPL.NS’s Enterprise Value compared to its peers?

Parenteral Drugs (India) Ltd.’s Enterprise Value is greater than Ganga Pharmaceuticals Limited (80.24M), greater than Ortin Laboratories Limited (159.91M), greater than Fabino Enterprises Ltd (63.77M), greater than Bafna Pharmaceuticals Limited (393.64M), less than Vivimed Labs Ltd. (4.17B),

Build a custom stock screener for Parenteral Drugs (India) Ltd. (PDPL.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Parenteral Drugs (India) Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Parenteral Drugs (India) Ltd. (PDPL.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Parenteral Drugs (India) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Parenteral Drugs (India) Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS)?

What is the 3-year average Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS)?

What is the 5-year average Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS)?

How does the current Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS) compare to its historical average?